ZA200006090B - Delavirdine tablet formulation. - Google Patents

Delavirdine tablet formulation.

Info

Publication number
ZA200006090B
ZA200006090B ZA200006090A ZA200006090A ZA200006090B ZA 200006090 B ZA200006090 B ZA 200006090B ZA 200006090 A ZA200006090 A ZA 200006090A ZA 200006090 A ZA200006090 A ZA 200006090A ZA 200006090 B ZA200006090 B ZA 200006090B
Authority
ZA
South Africa
Prior art keywords
delavirdine
tablet formulation
amount
superdisintegrant
binder
Prior art date
Application number
ZA200006090A
Other languages
English (en)
Inventor
Alice C Martino
Ashley H Bates
Walter Morozowich
Lee E John
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22214517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200006090(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA200006090B publication Critical patent/ZA200006090B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ZA200006090A 1998-06-11 2000-10-27 Delavirdine tablet formulation. ZA200006090B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8896098P 1998-06-11 1998-06-11

Publications (1)

Publication Number Publication Date
ZA200006090B true ZA200006090B (en) 2001-10-29

Family

ID=22214517

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200006090A ZA200006090B (en) 1998-06-11 2000-10-27 Delavirdine tablet formulation.

Country Status (21)

Country Link
US (3) US6177101B1 (ko)
EP (1) EP1083885B1 (ko)
JP (1) JP4827296B2 (ko)
KR (2) KR20070040426A (ko)
CN (1) CN1237958C (ko)
AT (1) ATE349203T1 (ko)
AU (1) AU753241C (ko)
BR (1) BR9910481A (ko)
CA (1) CA2328703C (ko)
CY (1) CY1105924T1 (ko)
DE (1) DE69934582T2 (ko)
DK (1) DK1083885T3 (ko)
EA (1) EA004311B1 (ko)
ES (1) ES2277682T3 (ko)
HK (1) HK1036417A1 (ko)
HU (1) HUP0102206A3 (ko)
NZ (1) NZ508762A (ko)
PL (1) PL200163B1 (ko)
PT (1) PT1083885E (ko)
WO (1) WO1999063970A1 (ko)
ZA (1) ZA200006090B (ko)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070040426A (ko) * 1998-06-11 2007-04-16 파마시아 앤드 업존 캄파니 엘엘씨 빠르게 침전하는 약물의 정제 제제
MXPA02006324A (es) 1999-12-23 2002-12-13 Pfizer Prod Inc Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco.
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
US20040243118A1 (en) * 2001-06-01 2004-12-02 Ayers Gregory M. Device and method for positioning a catheter tip for creating a cryogenic lesion
US20030073826A1 (en) * 2001-08-28 2003-04-17 Chao Robert S. Crystaline clindamycin free base
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
US20050163839A1 (en) * 2003-01-29 2005-07-28 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
JP2006522099A (ja) * 2003-04-04 2006-09-28 ファルマシア コーポレーション 複合粒状体からなる経口徐放性圧縮錠
WO2004110461A1 (en) 2003-06-13 2004-12-23 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
BRPI0412190A (pt) * 2003-07-01 2006-08-22 Pharmacia & Upjohn Co Llc sólidos com camada de difusão modulada
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050283146A1 (en) * 2004-06-17 2005-12-22 Lentz David J Thermally extended spiral cryotip for a cryoablation catheter
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
WO2008012991A1 (fr) 2006-07-27 2008-01-31 Kabushiki Kaisha Kobe Seiko Sho Dispositif de connexion et installation de malaxage possédant un dispositif de malaxage et un dispositif d'entraînement connectés l'un à l'autre par le dispositif de connexion
CA2617688C (en) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Solid dosage formulations containing weight-loss drugs
US8696606B2 (en) * 2009-09-28 2014-04-15 Continuous MotionFlow, LLC Passive motion machine with integrated mechanical DVT prophylactic therapy
ES2569925T3 (es) 2009-09-30 2016-05-13 Acura Pharmaceuticals, Inc. Métodos y composiciones de disuasión del abuso
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
US20120010216A1 (en) * 2010-07-06 2012-01-12 Brown Arthur M Pharmaceutical compositions containing vanoxerine
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
EA032913B1 (ru) 2012-10-18 2019-08-30 Эббви Инк. Препараты производных пиримидиндиона
RU2673818C2 (ru) 2012-11-30 2018-11-30 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
SG11201509998WA (en) 2013-06-13 2016-01-28 Akebia Therapeutics Inc Compositions and methods for treating anemia
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2019218958A1 (zh) * 2018-05-15 2019-11-21 江苏豪森药业集团有限公司 包含小分子egfr抑制剂的药物组合物及其制备方法
CN108619104A (zh) * 2018-06-29 2018-10-09 哈尔滨珍宝制药有限公司 一种基于盐酸克林霉素的药物组合物及其制备方法
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
ZA855250B (en) * 1984-08-17 1986-02-26 Upjohn Co Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
DE3708916A1 (de) 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
DE3868245D1 (de) * 1987-11-30 1992-03-12 Gist Brocades Nv Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
GB8824392D0 (en) * 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
CA2007764C (en) * 1989-02-24 1999-11-30 Joseph Michael Beaurline Salsalate tablet
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
NZ236393A (en) 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5663169A (en) * 1992-08-07 1997-09-02 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2711524B1 (fr) * 1993-10-21 1995-11-24 Rhone Dpc Europ Procédé de préparation de compositions orales contenant des quinolones.
PL180776B1 (pl) 1994-04-15 2001-04-30 Upjohn Co Sole monometanosulfoniany 1-[5-metanosulfonamidoindolilo-2-karbonylo]-4-[3-(1-metyloetyloamino)-2-pirydynylo] piperazyny
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5837292A (en) 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
KR20070040426A (ko) * 1998-06-11 2007-04-16 파마시아 앤드 업존 캄파니 엘엘씨 빠르게 침전하는 약물의 정제 제제

Also Published As

Publication number Publication date
BR9910481A (pt) 2001-01-09
KR20070040426A (ko) 2007-04-16
NZ508762A (en) 2003-07-25
KR20010052717A (ko) 2001-06-25
DK1083885T3 (da) 2007-02-26
CY1105924T1 (el) 2011-04-06
JP4827296B2 (ja) 2011-11-30
ES2277682T3 (es) 2007-07-16
EP1083885A1 (en) 2001-03-21
CN1237958C (zh) 2006-01-25
DE69934582T2 (de) 2007-10-04
CA2328703C (en) 2007-10-30
AU4213499A (en) 1999-12-30
US20060257476A1 (en) 2006-11-16
ATE349203T1 (de) 2007-01-15
EP1083885B1 (en) 2006-12-27
PT1083885E (pt) 2007-01-31
HK1036417A1 (en) 2002-01-04
JP2002517430A (ja) 2002-06-18
US6177101B1 (en) 2001-01-23
US7108864B1 (en) 2006-09-19
DE69934582D1 (de) 2007-02-08
AU753241C (en) 2003-05-08
HUP0102206A2 (hu) 2002-03-28
PL200163B1 (pl) 2008-12-31
CN1301149A (zh) 2001-06-27
WO1999063970A1 (en) 1999-12-16
PL344328A1 (en) 2001-10-22
AU753241B2 (en) 2002-10-10
EA200100024A1 (ru) 2001-06-25
CA2328703A1 (en) 1999-12-16
EA004311B1 (ru) 2004-02-26
HUP0102206A3 (en) 2002-12-28
KR100724016B1 (ko) 2007-05-31

Similar Documents

Publication Publication Date Title
PL344328A1 (en) Delavirdine tablet formulation
AU3080895A (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
HUP0100072A3 (en) Phenoxazine, phenthiazine derivatives, their use in medicine; process for their preparation and pharmaceutical compositions containing them
IE881916L (en) Press-coated dihydropyridine tablets
CA2216828A1 (en) Controlled release insufflation carrier for medicaments
CA2171844A1 (en) Sustained release formulations for 24 hour release of metoprolol
AU7196096A (en) Long-lasting release Nifedipine preparation
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
HUP0001652A3 (en) Oxadiazole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
CA2346001A1 (en) Controlled release nanoparticulate compositions
GR3035410T3 (en) Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions
IL110481A0 (en) 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
CA2214895A1 (en) Improved pharmaceutical composition comprising fenofibrate
WO1998022097A3 (en) Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
TR199901433T2 (xx) Pirolo$3,4-D] pirimidinon t�revleri ve bunlar�n ila� olarak kullan�mlar�.
DE69632194D1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
HUP0003577A3 (en) Tetrahydro gamma-carbolines, process for their preparation, their use and pharmaceutical compositions containing them
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HK1024695A1 (en) Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
AU5139596A (en) Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
MD970269A (en) Clavulanates
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
AU1606997A (en) Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs
MX9806292A (es) Formulacion de un inhibidor de la 5alfa-reductasa para su administracion oral, y un procedimiento de preparacion y uso del mismo.